Micro Labs Recalls Simvastatin Tablets Due to Impurity Failure
Micro Labs USA Inc. is recalling Simvastatin Tablets, 40mg, because the product failed a known impurity specification. The recall affects 13,488 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric indicates is typically a score of 1 or 2. Given the nature of the impurity failure, a score of 2 (Moderate) is appropriate as it is a voluntary precautionary recall for a specification failure without reported illness.
Plain-English summary
Micro Labs USA Inc. is recalling Simvastatin Tablets, USP, 40mg, Rx Only, 90 count bottles. The recall was initiated because the product failed a known impurity specification. The affected product is manufactured by Micro Labs Limited in India for Micro Labs USA Inc. in Princeton, NJ.
The recall involves 13,488 bottles of the medication. The specific lot number is STDG010, with an expiration date of 3/2015. The product was distributed nationwide.
Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on obtaining a replacement. The recall is classified as Class III by the FDA, indicating that use of or exposure to the product is not likely to cause adverse health consequences.
The recalled product
- Product
- Simvastatin Tablets, USP, 40mg, Rx Only, 90 count bottles, Manufactured by: Micro Labs Limited Goa-403 722, India, Manufactured for: Micro Labs USA Inc., Princeton, NJ 08540 NDC 42571-0040-90.
- Manufacturer
- Micro Labs Usa, Inc S
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 13,488
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: STDG010
- Exp 3/2015
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Micro Labs Usa, Inc S under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Micro Labs Usa, Inc S
See all →- LowMicro Labs Recalls Simvastatin Tablets Due to Impurity Failure
FDA (Drugs) · 2015-03-18
- ModerateMicro Labs Recalls Simvastatin Tablets Due to Impurity Failure
FDA (Drugs) · 2015-03-18
- SevereMicro Labs Recalls Losartan Potassium Tablets for Content Uniformity Failures
FDA (Drugs) · 2014-11-26
- LowMicro Labs Recalls Simvastatin Tablets Due to Impurity Specification Failure
FDA (Drugs) · 2014-11-19
- ModerateMicro Labs Recalls Glimepiride Tablets Due to Failed Stability Testing
FDA (Drugs) · 2014-11-05
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17